Fundraising FoxARCH Venture Partners — 2024 Investments
26 investments dated 2024 · listed companies and verified rows first · show all
Enliven Therapeutics is a clinical-stage biopharmaceutical company that discovers and develops small molecule therapeutics using a precision medicine approach, with a focus on oncology and hematology.
BiotechHealthtechBoulder, US
Sam Kintz(Co-founder and Head of Pipeline)inJoe Lyssikatos(Co-founder and Research Fellow)Anish Patel(Co-founder and Chief Operating Officer)Rick Fair(Chief Executive Officer and Member of the Board of Directors)inHelen Collins(Chief Medical Officer)inBen Hohl(Chief Financial Officer and Head of Corporate Development)in
Board seatRichard Heyman· per SEC Form D · $90M raise · filed Apr 2024
Co-investors5AM VenturesOrbiMedPfizer Venture InvestmentsRoche Venture FundBay City CapitalJanus Henderson Investors+2 more
Seaport Therapeutics develops therapeutics and medicines.
BiotechMental HealthBoston, US
Daphne Zohar(Founder, CEO & Board Member)inSteven Paul, M.D.(Founder, Board Chair)inMichael Chen, Ph.D.(Co-Founder, Chief Scientific Officer)Michael Chen(Executive Officer)inLana Gladstein(Executive Officer)inAntony Loebel(Executive Officer)in
Board seatRobert Nelsen· per SEC Form D
Co-investorsForesite CapitalGeneral AtlanticHAWKTAILPureTech HealthSofinnova VenturesCPP Investments+3 more
Voyager Therapeutics is a biotechnology company developing genetic medicines for neurological diseases of the central nervous system, including Alzheimer's disease, ALS, and Parkinson's disease.
BiotechHealthtechLexington, US
Todd Carter(Executive Officer)inRobin Swartz(Executive Officer)inAlfred Sandrock(Executive Officer, Director)Peter Pfreundschuh(Executive Officer)inNathan Jorgensen(Chief Financial Officer; Principal Financial Officer and Principal Accounting Officer)Steven Hyman(Director)
Board seatGeorge Scangos· per SEC Form D · $20M raise · filed Jan 2024
Co-investorsWellington ManagementFidelity InvestmentsThird Rock Ventures
Denali Therapeutics develops therapeutics for neurodegenerative diseases.
BiotechHealthtechMedical DevicesSan Francisco, US
Marc Tessier-Lavigne(Founder)inAlexander O. Schuth(Executive Officer)inRyan J. Watts(President, Chief Executive Officer and Director)inCarole Ho(Executive Officer)inSteve E. Krognes(Director)inAlexander Schuth(Founder)
Co-investorsEcoR1 CapitalF-Prime CapitalForesite CapitalGV (Google Ventures)Flagship PioneeringFlagship Ventures
Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)Rob Carson(Chief Executive Officer)inSimona Levi(Chief Legal Officer)in
Board seatKeith Crandell· per SEC Form D
Co-investorsNorthpond Ventures6 Dimensions CapitalAlly Bridge GroupApplied VenturesKilonova CapitalPura Vida Investments+3 more
Autobahn Therapeutics develops orally administered small molecule prodrugs using a brain-targeting chemistry platform to create regenerative medicines for central nervous system (CNS) disorders.
BiotechDeep TechMedical DevicesSan Diego, US
Kevin Finney(Chairman, President and CEO)inJohn Borkholder(Executive Officer)in
BoardThomas Cahill(Director)Timothy Anderson(Director)Philip J DeSouza(Director)
Board seatKristina Burow· per SEC Form D
Co-investorsCanaan PartnersMonograph Capital PartnersPfizer Venture InvestmentsSamsara BioCapitalInsight PartnersNewpath Partners
Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
BoardGeorge M. Church(Director)
Board seatSteven Gillis· per SEC Form D
Co-investorsAlta PartnersCatalio Capital Management, LPHBM Healthcare InvestmentsHBM PartnersKhosla VenturesLifeSci Venture Partners+12 more
Elephas develops elive, a live-tissue platform technology that predicts immunotherapy response in cancer patients by measuring real-time immune activity in intact tumor tissue.
BiotechDigital HealthHealthtechMedical DevicesMadison, US
Jonathan Oliner(Executive Officer)inManeesh Arora(Founder)inMichelle B. Arora(Director)Terrence P. Brady(Executive Officer)
Board seatPaul Berns· per SEC Form D
Co-investorsNorthpond VenturesSands Capital Ventures
Metsera was a clinical-stage biotechnology company developing injectable and oral medicines for obesity and metabolic diseases, including next-generation GLP-1 and amylin-based therapies.
BiotechHealthtechMedical DevicesNew York, US
Clive A. Meanwell(Director)Christopher J. Visioli(Executive Officer)inBrian Hubbard(Executive Officer)inChristopher Whitten Bernard(Executive Officer, Director)Steven Marso(Executive Officer)Clive Meanwell(Founder)
Board seatKristina BurowPaul Berns· per SEC Form D
Co-investorsAlpha Wave GlobalF-Prime CapitalGV (Google Ventures)RA CapitalSoftBank Vision FundViking Global+5 more
Mirador discovers and develops precision medicines for immune-mediated and immuno-fibrotic diseases using a target-patient matching approach.
AI & Machine LearningHealthtechMedical DevicesSan Diego, US
Mark C. McKenna(Executive Officer, Director)inJoseph Papa(Director)Scott Glenn(Director)Vika Brough(Executive Officer)Timothy K. Andrews(Executive Officer)Mark McKenna(Founder)
Board seatKristina BurowPaul Berns· per SEC Form D
Co-investorsAquiline Technology GrowthOrbiMedSanofi VenturesInvusPoint72Venrock Healthcare Capital Partners
Rippl delivers evidence-based dementia care through a combination of technology and human support for people living with dementia and their families.
Digital HealthHealthtechSeattle, US
Kris Engskov(Co-founder & CEO)inRobert Nelsen(Co-Founder & Board Chair)Paul Engskov(Executive Officer, Director)
BoardHolly Maloney(Director)inIyah Romm(Director)Ryan Watts(Director)
Board seatRobert Nelsen· per SEC Form D
Co-investors1843 CapitalCity LightEquitage Ventures, L.L.C.F-Prime CapitalGeneral CatalystGV (Google Ventures)+2 more
.png)
Seranova is a biotech company that combines REAP autoantibody profiling with clinically linked patient cohorts to identify naturally occurring protective autoantibodies against specific extracellular targets and translate those protective associations into therapeutic hypotheses.
AI & Machine LearningBiotechDeep TechNew Haven, US
Aaron Ring(Manager)inBeatrice McQueen(Executive Officer)
BoardJim Tananbaum(Manager)
Board seatSabah Oney· per SEC Form D · $10M raise · filed Feb 2024
Co-investorsAxial VCForesite Capital
Slingshot Biosciences makes synthetic cell mimics used as standardized reference controls for flow cytometry and cell-based assays.
Emeryville, US
Jeff Kim(Founder)inAdam Wieschhaus(Director)Ronald J. Silberman(Director)
Board seatCorey RitterPatrick Weiss· per SEC Form D
Co-investorsAnterra CapitalNorthpond Ventures
Accompany was a relationship intelligence and business insights platform that has been acquired by Cisco and integrated into their collaboration products suite.
Enterprise SoftwareSaaS
Ryan McDonough(Founder)inAmy Chang(Founder)Matthias Ruhl(Founder)
Co-investorsCowboy VenturesCRV (Charles River Ventures)Vista Venture PartnersICONIQ CapitalIVP (Institutional Venture Partners)Venrock
Arsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors.
BiotechHealthtechMedical DevicesSouth San Francisco, US
Ken Drazan(Founder)James Ahlers(Executive Officer)Irene Pleasure(Executive Officer)Margaret Nibbi(Executive Officer)Alexander Marson(Founder)Kole Roybal(Founder)
Co-investorsHitachi VenturesKleiner PerkinsLuma GroupOUP (Osage University Partners)SoftBank Vision FundWestlake Village BioPartners+4 more
City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.
BiotechMedical DevicesCambridge, US
Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)Andy Orth(Chief Executive Officer)in
Co-investorsAN Venture PartnersSofinnova VenturesViking GlobalAltitude Ventures Management, LlcCasdin CapitalFidelity Investments+5 more
Countable Labs (formerly Enumerix) develops a digital PCR platform that performs genetic analysis with higher sensitivity, precision, and dynamic range than legacy PCR methods.
AI & Machine LearningBiotechDeep TechMedical Devices
Biotech company developing antibodies to treat autoimmune and inflammatory diseases.
Co-investorsAlpha Wave GlobalArkin CapitalArkin Digital HealthJeito CapitalMonograph Capital PartnersViking Global+1 more
A manufacturing company focused on domestic production of robotics, aiming to build large-scale factories and apply AI in manufacturing.
Advanced ManufacturingAI & Machine LearningRobotics
Co-investorsPax VenturesScribble VenturesThe Westly GroupCollaborative FundExor Ventures
Matter is a read-later app for iPhone, iPad, and web that saves articles, newsletters, threads, PDFs, and video/podcast content with parsing and search capabilities.
ConsumerMedia & EntertainmentSaaSSan Francisco, US
Ben Springwater(Founder)inRobert Mackenzie(Founder)inNicolas Machado(Designer)in
Co-investorsAdapt VenturesGV (Google Ventures)Outliers VCY CombinatorAndreessen HorowitzCollaborative Fund+12 more
Matter develops a consumer iOS app that helps users track positive emotions and brain activity to improve subjective well-being.
AI & Machine LearningConsumerHealthtechMental HealthWellness & Fitness
Axel Bouchon(Founder)inBen Goldhirsh(Co-founder)inChris Shiflett(Co-founder)in
Co-investorsCollaborative FundExor VenturesPolaris Partners
nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications.
BiotechDeep TechMedical DevicesBoston, US
Luke Gilbert, PhD(Founder)Keith Joung, MD, PhD(Founder)David Liu, PhD(Founder)Angelo Lombardo, PhD(Founder)Luigi Naldini, MD, PhD(Founder)Jonathan Weissman, PhD
Co-investorsAtlas VentureNewpath Partners5AM VenturesDCVC (Data Collective)F-Prime CapitalGV (Google Ventures)+11 more
Moonwalk Biosciences is a life sciences company operating in the biotech sector.
AI & Machine LearningBiotechDeep TechHealthtechSouth San Francisco, US
Arash Jamshidi(Founder)inAlex Aravanis(Co-Founder & CEO)inAlexander Aravanis(Founder)Feng Zhang(Founder)
Co-investorsAlpha Wave GlobalKhosla VenturesFuture VenturesGV (Google Ventures)YK Bioventures
Quantum Circuits develops superconducting quantum computers using dual-rail qubits with built-in error detection, designed to accelerate the path to fault-tolerant quantum computing.
Advanced ManufacturingDeep TechHardwareQuantum ComputingMadison, US
Rob Schoelkopf(Sterling Professor, Founder)inLuigi Frunzio(Founder)Ray SmetsinMichel Devoret(Founder)Robert Schoelkopf(Founder)
Co-investorsCanaan PartnersConnecticut InnovationsF-Prime CapitalFitz Gate VenturesIn-Q-TelOUP (Osage University Partners)+2 more
Xaira develops AI and machine learning tools for drug discovery and protein design, serving pharmaceutical and biotech companies.
AI & Machine LearningBiotechMedical DevicesSouth San Francisco, US
Hetu Kamisetty(Founder)Marc Tessier-Lavigne(Founder)inDr. Ci Chu(Chief Discovery Officer)Dr. Bo Wang(Chief AI Scientist)Dr. Ian McCaffery(SVP, Translational Science and Early Clinical Development)Bob Nelsen(Founder)
Co-investorsBreyer CapitalDeviation CapitalF-Prime CapitalForesite CapitalLongwood FundMenlo Ventures+5 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.